Jim Simons
DNA icon

Jim Simons’s Ginkgo Bioworks DNA Stock Holding History

Jim Simons’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$616K Buy
+100,456
New +$836K ﹤0.01% 2514
2025
Q1 		– Sell
-114,654
Closed -$1.13M – 3537
2024
Q4 		$1.13M Buy
114,654
+45,200
+65% +$387K ﹤0.01% 2431
2024
Q3 		$566K Sell
69,454
-89,719
-56% -$899K ﹤0.01% 2734
2024
Q2 		$2.13M Buy
+159,173
New +$4.75M ﹤0.01% 1847
2022
Q3 		– Sell
-78,535
Closed -$7.48M – 4084
2022
Q2 		$7.48M Buy
78,535
+44,552
+131% +$5.43M 0.01% 1280
2022
Q1 		$5.48M Buy
+33,983
New +$6.61M 0.01% 1524

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jim Simons's DNA Position: Q1 2026 in Review

Jim Simons opened a new position in Ginkgo Bioworks (DNA) in Q1 2026: 100,456 shares worth $616K. The stake represents ﹤0.01% of the portfolio and ranks #2514 among its holdings. This is a return to the name: Jim Simons previously reported a position in DNA as recently as Q4 2024.

Jim Simons first reported a position in DNA in Q1 2022 and has held it in 6 quarters since. The position peaked at $7.48M in Q2 2022. 175 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Jim Simons held 100,456 shares of Ginkgo Bioworks worth $616K as of Q1 2026.
  • Ginkgo Bioworks was a new Jim Simons position in Q1 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2514 holding.
  • Jim Simons first reported a position in Ginkgo Bioworks in Q1 2022 and has held it in 6 quarters since.
  • Jim Simons's Ginkgo Bioworks position peaked at $7.48M in Q2 2022.
  • 175 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.